ProPhase Labs (PRPH) reported Q3 EPS of $0.06, $0.13 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $24.2 million versus the consensus estimate of $18.42 million.
ProPhase Labs (PRPH) reported Q3 EPS of $0.06, $0.13 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $24.2 million versus the consensus estimate of $18.42 million.